Harvard Bioscience (HBIO) Cash & Equivalents Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -23.33% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 21.89% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 78.03% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 29.00% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 19.45% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.40% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.94% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 27.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.98% |
| Dec 31, 2025 | 109.69% |
| Sep 30, 2025 | 49.20% |
| Jun 30, 2025 | 83.84% |
| Mar 31, 2025 | 30.34% |
| Dec 31, 2024 | -4.09% |
| Sep 30, 2024 | -14.44% |
| Jun 30, 2024 | -6.38% |
| Mar 31, 2024 | 12.30% |
| Dec 31, 2023 | -4.99% |
| Sep 30, 2023 | 3.81% |
| Jun 30, 2023 | 1.53% |
| Mar 31, 2023 | -30.26% |
| Dec 31, 2022 | -42.36% |
| Sep 30, 2022 | -7.28% |
| Jun 30, 2022 | -31.71% |
| Mar 31, 2022 | -6.57% |
| Dec 31, 2021 | -5.96% |
| Sep 30, 2021 | 97.72% |
| Jun 30, 2021 | 137.24% |